MyHealthChecked PLC Directorate Change (8046D)
June 26 2023 - 1:00AM
UK Regulatory
TIDMMHC
RNS Number : 8046D
MyHealthChecked PLC
26 June 2023
MyHealthChecked PLC
( " MyHealthChecked " or the "Company " )
Directorate Change
Appointment of Non-Executive Director
MyHealthChecked PLC (AIM: MHC), the consumer home-testing
healthcare company, announces the proposed appointment of Amber
Vodegel as a Non-Executive Director of the Company with effect 3
July 2023.
Amber is the Founder and original Owner of Health and Parenting
Ltd, a HealthTech company that created the Company's flagship
application Pregnancy+, one of the largest pregnancy apps
worldwide, growing the user base to over two million daily active
users. Amber managed Pregnancy+ as part of a suite of health apps
under Health & Parenting Ltd from 2012 until the company was
acquired by Philips in 2017. Following the acquisition she held the
position of Business Leader and Transformation Advisor within
Philips BG MCC. Amber has worked with MyHealthChecked in an
advisory capacity for the past 5 months and brings to
MyHealthChecked a strong knowledge of digital strategy in the
healthcare space and a global network of contacts. Amber also
brings experience in mobile app development, digital
transformation, and platform development for the Health- and
FemTech space, with a focus on driving consumer obsession and
maximising user engagement. Previously, Amber worked as a Strategy
Director at a digital advertising agency with a focus on large
social media campaigns as well as helping various Apps reach the
number one position in their category.
Amber is the winner of the UK's 'First Women of Healthcare
Award' and was shortlisted for the 2016 NatWest 'everywoman
Awards'.
Penny McCormick, Chief Executive Officer of MyHealthChecked PLC,
said: " It is a pleasure to welcome Amber to the Board of
MyHealthChecked. Amber brings with her not only a wealth of
experience in the health tech sector but also a passion and
commitment to quality, ethics and the use of innovative technology
to make the world a better place. Amber's experience in digital
strategy hugely complements our business strategy and she is a
fantastic addition to the MyHealthChecked team and our Board of
Directors."
Commenting, Amber Vodegel, said: "I am thrilled to be part of
the Board of MyHealthChecked, as my passion lies in supporting
businesses that disrupt existing markets and create a positive
impact in healthcare. Joining forces with this passionate team is
truly a privilege, especially considering their impressive
achievements through the successful launch of the innovative
at-home testing range. It is an incredibly exciting time to be
joining the business and I look forward to contributing to its
growth."
The following additional information is provided in accordance
with paragraph (g) of Schedule Two to the AIM Rules for
Companies:
Amber Ilja Vodegel (49) is currently or has been a director of
the following companies within the previous five years:
Current directorships/partnerships Past directorships/partnerships
Consulens Limited Ambion Consulting Ltd
Ambion Investment Ltd
--------------------------------
Ms Vodegel holds no ordinary shares in the Company.
Save as set out above, no further information is required to be
disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules
for Companies.
For further information contact:
MyHealthChecked PLC www.myhealthchecked.com
Penny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin / Jade Bayat
Dowgate Capital Limited (Broker) Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44
(0)7407 804 654
About MyHealthChecked PLC (
https://investors.myhealthchecked.com/ )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home
rapid tests, as well as DNA, RNA and blood sample collection kits
which have been created to support customers on their journeys to
wellness. The tests are lateral-flow self-tests, whilst the sample
collection kits enable the collection of blood, urine, nasal or
mouth swab samples that are analysed in partner laboratories for a
range of biomarkers. The tests will also be made available online
and will be viable for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014
WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL)
ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO
BE IN THE PUBLIC DOMAIN.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAMZGZVNFRGFZM
(END) Dow Jones Newswires
June 26, 2023 02:00 ET (06:00 GMT)
MyHealthChecked (AQSE:MHC.GB)
Historical Stock Chart
From Aug 2024 to Sep 2024
MyHealthChecked (AQSE:MHC.GB)
Historical Stock Chart
From Sep 2023 to Sep 2024